| BID | 2.20 | ASK | 2.29 | ||
| Open | 2.20 | Previous Close | 2.21 | ||
| Pre-Market | - | After-Market | - | ||
| - - | - -% |
| Target Price | 13.00 | Analyst Rating | Strong Buy 1.50 | |
| Potential % | 477.78 | Finscreener Ranking | — - | |
| Insiders Trans % 3/6/12 mo. | -/100/100 | Value Ranking | ★+ 42.08 | |
| Insiders Value % 3/6/12 mo. | -/100/100 | Growth Ranking | — - | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/100/100 | Income Ranking | — - | |
| Price Range Ratio 52W % | 7.26 | Earnings Rating | — | |
| Market Cap | 73.31M | Earnings Date | 13th Nov 2023 | |
| Alpha | -0.03 | Standard Deviation | 0.23 | |
| Beta | 1.01 |
Today's Price Range 2.202.25 | 52W Range 2.005.45 |
Summary:
Sell
| Technical Indicators: | Sell |
| Moving Averages: | Strong Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | 4.65% | ||
| 1 Month | -12.45% | ||
| 3 Months | -4.86% | ||
| 6 Months | -28.34% | ||
| 1 Year | -36.31% | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | - | |||
ROE last 12 Months | -136.93 | |||
ROA (5Y Avg) | - | |||
ROA last 12 Months | -56.14 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -63.11 | |||
Return on invested Capital Q | -12.22 | |||
Return on invested Capital Y | -60.71 | |||
Assets Turnover | 0.20 | |||
Receivables Turnover | 2.80 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -2.60 | ||||
| 5.62 | ||||
| 3.73 | ||||
| - | ||||
| -7.50 | ||||
| -0.41 | ||||
| -38.15 | ||||
| 0.44 | ||||
| 85.55M | ||||
| Forward PE | - | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 3.10 | ||||
| 3.30 | ||||
| 0.64 | ||||
| 1.79 | ||||
| -33.60 | ||||
| Leverage Ratio | 2.90 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 73.10 | ||||
| -114.30 | ||||
| -103.20 | ||||
| - | ||||
| - |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 20.10M | ||||
| 0.62 | ||||
| - | ||||
| - |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q01 2024 | - | -0.03 | - |
| Q01 2023 | - | -0.08 | - |
| Q03 2022 | - | -0.16 | - |
| Q02 2022 | - | -0.17 | - |
| Q01 2022 | - | -0.21 | - |
| Q04 2021 | - | -0.25 | - |
| Q03 2021 | - | -0.22 | - |
| Q02 2021 | - | -0.23 | - |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Next Report Date | 13th Nov 2023 |
| Estimated EPS Next Report | - |
| Estimates Count | - |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 2.70K |
| Shares Outstanding | 32.58K |
| Shares Float | 17.00M |
| Trades Count | 141 |
| Dollar Volume | 5.97K |
| Avg. Volume | 12.30K |
| Avg. Weekly Volume | 18.07K |
| Avg. Monthly Volume | 9.64K |
| Avg. Quarterly Volume | 9.17K |
Forian Inc. (NASDAQ: FORA) stock closed at 2.25 per share at the end of the most recent trading day (a 1.81% change compared to the prior day closing price) with a volume of 2.70K shares and market capitalization of 73.31M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 133 people. Forian Inc. CEO is Daniel Barton.
The one-year performance of Forian Inc. stock is -36.31%, while year-to-date (YTD) performance is -17.58%. FORA stock has a five-year performance of %. Its 52-week range is between 2 and 5.445, which gives FORA stock a 52-week price range ratio of 7.26%
Forian Inc. currently has a PE ratio of -2.60, a price-to-book (PB) ratio of 5.62, a price-to-sale (PS) ratio of 3.73, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -56.14%, a ROC of -63.11% and a ROE of -136.93%. The company’s profit margin is -%, its EBITDA margin is -103.20%, and its revenue ttm is $20.10 Million , which makes it $0.62 revenue per share.
Of the last four earnings reports from Forian Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Forian Inc.’s next earnings report date is 13th Nov 2023.
The consensus rating of Wall Street analysts for Forian Inc. is Strong Buy (1.5), with a target price of $13, which is +477.78% compared to the current price. The earnings rating for Forian Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Forian Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Forian Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 17.91, ATR14 : 0.14, CCI20 : -74.21, Chaikin Money Flow : -0.18, MACD : -0.08, Money Flow Index : 32.97, ROC : -5.46, RSI : 44.53, STOCH (14,3) : 26.72, STOCH RSI : 0.89, UO : 45.86, Williams %R : -73.28), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Forian Inc. in the last 12-months were: Martin J. Wygod (Buy at a value of $40 996), Martin Wygod (Buy at a value of $100 283), Max C. Wygod (Buy at a value of $19 300), Max Wygod (Buy at a value of $19 300), Stanley Trotman (Buy at a value of $48 000)
Forian Inc.
Forian Inc provides a suite of SaaS solutions, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments, as well as cannabis dispensaries, manufacturers, cultivators, and regulators.
CEO: Daniel Barton
Telephone: +1 267 757-8707
Address: 41 University Drive, Newtown 18940, PA, US
Number of employees: 133
